Details for New Drug Application (NDA): 213766
✉ Email this page to a colleague
NDA 213766 describes CALCITONIN-SALMON, which is a drug marketed by Cipla, Custopharm Inc, Dr Reddys, Endo Operations, Igi Labs Inc, and Apotex Inc, and is included in seven NDAs. It is available from six suppliers. Additional details are available on the CALCITONIN-SALMON profile page.
The generic ingredient in CALCITONIN-SALMON is calcitonin salmon. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
The generic ingredient in CALCITONIN-SALMON is calcitonin salmon. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.
Summary for 213766
| Tradename: | CALCITONIN-SALMON |
| Applicant: | Cipla |
| Ingredient: | calcitonin salmon |
| Patents: | 0 |
Suppliers and Packaging for NDA: 213766
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CALCITONIN-SALMON | calcitonin salmon | INJECTABLE;INJECTION | 213766 | ANDA | Cipla USA Inc. | 69097-770 | 69097-770-32 | 1 VIAL, MULTI-DOSE in 1 CARTON (69097-770-32) / 2 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 200 IU/ML | ||||
| Approval Date: | Sep 20, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
